SCHEMBL18825083

SCHEMBL18825083

CCCCCc1cc2cc(C)cc([N+](=O)[O-])c2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPT P10636 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
GPR84 Q9NQS5 12/20 0.40
KMT2A Q03164 1/20 0.38
GPR35 Q9HC97 1/20 0.38
NPY5R Q15761 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18825093 0.90 GRIN2D (0.47) ALDH1A1L3MBTL1MAPTTDP1GRIN2D
SCHEMBL18825080 0.82 CYP3A4 (0.48) ALDH1A1MAPTTDP1GPR84CYP3A4
SCHEMBL27762914 0.79 GRIN2D (0.42) ALDH1A1L3MBTL1MAPTTDP1GRIN2D
SCHEMBL22547495 0.71 GPR84 (0.67) GPR84KMT2A
SCHEMBL3416258 0.70 FBP1 (0.49) ALDH1A1MAPTGRIN2DGRIN3BGRIN1
SCHEMBL8160462 0.70 GPR84 (0.70) GPR84KMT2A
SCHEMBL1277858 0.69 RAB9A (0.52) ALDH1A1L3MBTL1MAPTGRIN2DGRIN3B
SCHEMBL2768879 0.69 FBP1 (0.64) ALDH1A1MAPTGRIN2DGRIN3BGRIN1
SCHEMBL28923795 0.69 KCNH2 (0.50) ALDH1A1MAPTKMT2A
SCHEMBL9015135 0.68 GPR84 (0.45) GPR84KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017077307-A1 THERAPY AND PHARMACEUTICAL COMPOSITION UNIVERSITY OF SOUTHAMPTON (GB) 2017-05-11 WO disclosed
WO-2017077307-A1 THERAPY AND PHARMACEUTICAL COMPOSITION UNIVERSITY OF SOUTHAMPTON (GB) 2017-05-11 WO disclosed